[Other] Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study

geovane.mgs Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-31 11:28
Reward20points

journal:Journal of Clinical Oncology

Authors:Yuanyuan Zhao; Hongyun Zhao; Qiming Wang; Kunyu Yang; Yongsheng Li; Zhenming Fu; Weihua Yang; Zhiyong He; Yongsheng Wang; Yuxiang Ma; Yunpeng Yang; Wenfeng Fang; Sa Xiao; Hai Zhu; Yi Zhu; Li Zhang; Yan Huang

Published date:--

DOI:10.1200/jco-26-00243

PDF link:https://ascopubs.org/doi/pdfdirect/10.1200/JCO-26-00243

Article link:https://doi.org/10.1200/jco-26-00243

Article Source:American Society of Clinical Oncology (ASCO)


Remark:
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    110


Return to the list